Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers
- 1 May 1993
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 33 (8-9) , 636-641
- https://doi.org/10.1016/0006-3223(93)90103-k
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brainNeuropharmacology, 1992
- Abnormalities in the Regulation of Vasopressin and Corticotropin Releasing Factor Secretion in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1992
- Personality and Cerebrospinal Fluid Monoamine Metabolites in Alcoholics and ControlsArchives of General Psychiatry, 1991
- Monoamine Neurotransmitter Interactions and the Prediction of Antidepressant ResponseArchives of General Psychiatry, 1987
- FluoxetineDrugs, 1986
- Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levelsActa Psychiatrica Scandinavica, 1986
- Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor ? a dose-response study in depressed patientsPsychopharmacology, 1985
- CSF monoamine metabolites in melancholiaActa Psychiatrica Scandinavica, 1984
- Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptorsBiochemical Pharmacology, 1983
- Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sexNeuropharmacology, 1971